SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-11-002096
Filing Date
2011-02-08
Accepted
2011-02-08 07:13:06
Documents
2
Period of Report
2011-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2206
2 poa.txt EX-24 3190
  Complete submission text file 0001179110-11-002096.txt   7140
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Issuer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7015 ALBERT EINSTEIN DR COLUMBIA MD 21046
Business Address
Potter Stephen W (Reporting) CIK: 0001511991 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32966 | Film No.: 11580279